Not Signed In -
Osteoporosis |
Bone Loss |
Clinical Trial: Osteoporosis Disease Management Demonstration Project
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to assess the impact of disease management interventions on bone mineral density (BMD) screening rates and osteoporosis treatment rates in women age 65 years or older.
| Condition | Intervention |
|---|---|
| Osteoporosis | Behavior: Disease Management Assessment |
MedlinePlus related topics: Osteoporosis
Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Placebo Control, Parallel Assignment
Official Title: Osteoporosis Prevention and Treatment Program: A Disease Management Demonstration Project
Further Study Details:
Primary Outcomes: Bone mineral density (BMD) testing rates
Secondary Outcomes: Osteoporosis medication treatment rates
Expected Total Enrollment: 10000
Secondary Outcomes: Osteoporosis medication treatment rates
Expected Total Enrollment: 10000
Study start: May 2003
Eligibility
Ages Eligible for Study: 65 Years - 89 Years, Genders Eligible for Study: Female
Criteria
Inclusion Criteria:
- Members of the Henry Ford Health System
Exclusion Criteria:
- Individuals who are not members of the Henry Ford Health System
Location Information
Study chairs or principal investigators
Medical Monitor, Study Director, Merck
More Information
Study ID Numbers: 2005_048
Last Updated: September 7, 2005
Record first received: August 29, 2005
ClinicalTrials.gov Identifier: NCT00139425
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-13
Last Updated: September 7, 2005
Record first received: August 29, 2005
ClinicalTrials.gov Identifier: NCT00139425
Health Authority: United States: Institutional Review Board
ClinicalTrials.gov processed this record on 2005-09-13
email this page
print this page
bookmark this page
feedback on this page
